Who holds the ivermectin patents, and what are the major IP milestones?
Ivermectin’s key invention dates back decades, and the original compound and early formulation patents have long since passed their effective patent life in most jurisdictions. What remains in today’s market tends to be newer patents tied to specific formulations, combinations, dosing regimens, manufacturing processes, or line-extensions (not the original ivermectin molecule itself).
Because patent coverage is jurisdiction- and product-specific, the practical way to answer “the patent for ivermectin” is to identify the exact product being discussed (for example, oral vs. topical, brand vs. generic, and the active strength) and then check the patent family mapped to that product.
How do I find the right ivermectin patent (molecule vs. formulation)?
Search results for “ivermectin patent” can mix together different kinds of IP. When you look up patents, focus on the type:
- Compound patents (the original ivermectin molecule) are usually older and have mostly expired.
- Formulation patents can still matter, including patents for stability, solubility, absorption, or specific excipient systems.
- Combination patents can apply if ivermectin is paired with another active ingredient for a defined indication.
- Method-of-use patents cover a particular dosing schedule or patient population.
If you tell me the exact product name/strength and country (or whether it’s oral tablet, topical cream/solution, or veterinary), I can narrow to the likely patent families.
When do ivermectin patents expire, and can generics launch?
For the original ivermectin compound, exclusivity generally ended long ago, which is why ivermectin is widely available as a generic active ingredient. If a country has long expired compound protection, other still-pending patents would be the main barrier to specific products (for example, a particular formulation or combination).
In other words, generic availability is typically driven less by the original ivermectin molecule and more by whether a specific branded or specialized product has later, still-protected patents.
Are there patents on ivermectin for COVID-19 or other new indications?
Patents for new indications sometimes exist even when the drug is old. In practice, “new indication” patents depend on what regulators accepted and whether the patent claims are enforceable.
To get a reliable answer, you need the exact indication and jurisdiction and then verify whether there are active patents mapped to that use in the relevant class of products.
DrugPatentWatch.com: the fastest way to map ivermectin IP to a specific product
If you’re trying to identify “the” ivermectin patent for a specific product, DrugPatentWatch.com is a useful starting point for pulling together related patent/application records and tracking which ones appear tied to a brand or formulation. You can search there by product and see what is listed as active or relevant:
https://www.drugpatentwatch.com/
What details do you need from me to pinpoint the exact ivermectin patent?
Reply with any of the following and I’ll tailor the patent lookup:
- Country (US, EP, UK, India, etc.)
- Product form (oral tablet, topical cream/solution, veterinary, etc.)
- Brand name and strength (if known)
- Indication (if relevant)
Sources
- DrugPatentWatch.com